Circulating tumor cells (CTCs) and cytokeratin 19 (CK19) mRNA as prognostic factors in heavily pretreated patients with metastatic breast cancer

S. Morales,A. Velasco, A. Gasol, F. Córdoba,J. Vidal, A. Serrate,J. Valls,J.C. Samame, R. Gisbert, D. Moral,A. Llombart-Cussac,A. Salud, X. Matias-Guiu

Cancer Treatment and Research Communications（2018）

引用 3|浏览21

暂无评分

摘要

CK19 mRNA expression and CTC count appeared clinically meaningful in pretreated patients with MBC, even when adjusted for phenotype and visceral disease involvement. These results support the use of CK19 and CTC as relevant biomarkers for predicting clinical response in MBC.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要